Annovis Financial Statements From 2010 to 2022

ANVS
 Stock
  

USD 12.25  0.05  0.41%   

Annovis Bio financial statements provide useful quarterly and yearly information to potential Annovis Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Annovis Bio financial statements helps investors assess Annovis Bio's valuation, profitability, and current liquidity needs.
There are over fourty available fundamental signals for Annovis Bio, which can be analyzed over time and compared to other ratios. Please make sure to validate Annovis Bio's prevailing fundamental performance against the performance between 2010 and 2022 to make sure the trends are evolving in the right direction.
Annovis Bio Tangible Asset Value is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Tangible Asset Value of 46 Million. As of 06/28/2022, Working Capital is likely to grow to about 48 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.9 M).
  
Refresh
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis main balance sheet or income statement drivers, such as Operating Expenses of 15.7 M, Research and Development Expense of 9.1 M or Selling General and Administrative Expense of 4.8 M, as well as many exotic indicators such as Book Value per Share of 6.3, Current Ratio of 32.94 or Debt to Equity Ratio of 0.0367. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules. It can also supplement various Annovis Bio Technical models. Please continue to the analysis of Annovis Bio Correlation against competitors.

Annovis Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets49.6 M46 M8.1 M
Increasing
Slightly volatile
Cash and Equivalents49.3 M45.7 MM
Increasing
Slightly volatile
Trade and Non Trade Receivables657.7 K661.6 K723.5 K
Decreasing
Slightly volatile
Trade and Non Trade Payables699.7 K688.1 K275.3 K
Increasing
Slightly volatile
Total Liabilities1.6 M1.5 M874.5 K
Increasing
Slightly volatile
Shareholders Equity48 M44.5 M1.8 M
Increasing
Slightly volatile
Current Assets49.6 M46 M8.1 M
Increasing
Slightly volatile
Assets Non Current330.7 K332.6 K363.8 K
Decreasing
Slightly volatile
Current Liabilities1.5 M1.5 M821.2 K
Increasing
Slightly volatile
Liabilities Non Current542 K545.2 K596.2 K
Decreasing
Slightly volatile
Total Debt447.2 K449.8 K491.9 K
Decreasing
Slightly volatile
Debt Non Current447.2 K449.8 K491.9 K
Decreasing
Slightly volatile
Shareholders Equity USD48 M44.5 M1.8 M
Increasing
Slightly volatile
Cash and Equivalents USD49.3 M45.7 MM
Increasing
Slightly volatile
Total Debt USD447.2 K449.8 K491.9 K
Decreasing
Slightly volatile

Annovis Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General and Administrative Expense4.8 M6.1 M1.6 M
Increasing
Slightly volatile
Research and Development Expense9.1 M8.5 M1.7 M
Increasing
Slightly volatile
Operating Expenses15.7 M14.5 M3.5 M
Increasing
Slightly volatile
Weighted Average Shares6.1 M7.6 M1.8 M
Increasing
Slightly volatile
Weighted Average Shares Diluted6.1 M7.6 M1.8 M
Increasing
Slightly volatile

Annovis Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow from Financing50.4 M46.7 M8.6 M
Increasing
Slightly volatile
Issuance Repayment of Debt Securities 474.2 K477 K521.6 K
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares50.4 M46.7 M9.3 M
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents40.6 M37.6 M6.4 M
Increasing
Slightly volatile
Share Based Compensation5.1 M4.7 M952.6 K
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Return on Average Equity(0.43)(0.402)(0.0152)
Decreasing
Slightly volatile
Return on Invested Capital15.3914.6225.7581
Increasing
Slightly volatile
Price to Book Value3.813.2016.3702
Decreasing
Slightly volatile
Debt to Equity Ratio0.03670.034(0.064)
Increasing
Stable
Current Ratio32.9430.5356.0538
Increasing
Slightly volatile
Book Value per Share6.35.834(20.2488)
Increasing
Slightly volatile
Tangible Assets Book Value per Share4.836.0321.3662
Increasing
Slightly volatile

Annovis Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization131.2 M142.4 M65 M
Increasing
Slightly volatile
Enterprise Value89.9 M95 M50.7 M
Increasing
Slightly volatile
Average Equity38.8 M36 M246.6 K
Increasing
Slightly volatile
Average Assets40.2 M37.3 M7.2 M
Increasing
Slightly volatile
Tangible Asset Value49.6 M46 M8.1 M
Increasing
Slightly volatile
Working Capital48 M44.5 M7.2 M
Increasing
Slightly volatile

Annovis Fundamental Market Drivers

Short Percent Of Float3.07%
Forward Price Earnings-4.40
Shares Short Prior Month279.58k
Average Daily Volume Last 10 Day44.03k
Average Daily Volume In Three Month40.16k
Date Short Interest29th of April 2022
Fifty Day Average10.56
Two Hundred Day Average18.67

Annovis Upcoming Events

Upcoming Quarterly Report2nd of March 2022
Next Fiscal Quarter End31st of December 2021

About Annovis Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Annovis Bio income statement, its balance sheet, and the statement of cash flows. Annovis Bio investors use historical funamental indicators, such as Annovis Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may use each financial statement separately, they are all related. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Annovis Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Annovis Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Annovis Bio. Please read more on our technical analysis and fundamental analysis pages.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people.

Annovis Bio Investors Sentiment

The influence of Annovis Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Annovis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Annovis Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Annovis Bio's short interest history, or implied volatility extrapolated from Annovis Bio options trading.

Current Sentiment - ANVS

Annovis Bio Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in Annovis Bio. What is your sentiment towards investing in Annovis Bio? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish

Pair Trading with Annovis Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will appreciate offsetting losses from the drop in the long position's value.

Annovis Bio Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Annovis Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis Bio to buy it.
The correlation of Annovis Bio is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Annovis Bio Correlation against competitors. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
99.6 M
Return On Assets
-0.44
Return On Equity
-0.74
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.